Lucknow Speciality Pharma
Ixazomib Capsules, In November 2015, the US FDA approved ixazomib for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
Ixazomib Capsules
- Generic Brand Available – Ninlaro
- API – Ixazomib
- Packaging – 3 Packs
- Strength – 4 mg
What is Ixazomib Capsules used for?
Ixazomib Capsules are used in combination with lenalidomide and dexamethasone to treat multiple myeloma (a type of bone marrow cancer) in patients who have received at least one prior treatment. It interferes with the growth of cancer cells, which are eventually destroyed by the body.
Facts of Medicines
STORAGE AND HANDLING
Store NINLARO at room temperature. Do not store above 30°C (86°F). Do not freeze. Store capsules in original packaging until immediately prior to use.
DOSAGE
The recommended starting dose of NINLARO is 4 mg administered orally once a week on Days 1, 8, and 15 of a 28-day treatment cycle.
The recommended starting dose of lenalidomide is 25 mg administered daily on Days 1 through 21 of a 28-day treatment cycle.
The recommended starting dose of dexamethasone is 40 mg administered on Days 1, 8, 15, and 22 of a 28-day treatment cycle.
SIDE EFFECTS
The following adverse reactions are described in detail in other sections of the prescribing information: Thrombocytopenia, Gastrointestinal Toxicities, Peripheral Neuropathy, Peripheral Edema, Cutaneous Reactions, Thrombotic Microangiopathy, Hepatotoxicity,
WARNINGS AND PRECAUTIONS
Thrombocytopenia has been reported with NINLARO with platelet nadirs typically occurring between Days 14-21 of each 28-day cycle and recovery to baseline by the start of the next cycle. Three percent of patients in the NINLARO regimen and 1% of patients in the placebo regimen had a platelet count ≤ 10,000/mm3 during treatment. Less than 1% of patients in both regimens had a platelet count ≤ 5000/mm3 during treatment. Discontinuations due to thrombocytopenia were similar in both regimens (< 1% of patients in the NINLARO regimen and 2% of patients in the placebo regimen discontinued one or more of the three drugs).The rate of platelet transfusions was 6% in the NINLARO regimen and 5% in the placebo regimen.
Monitor platelet counts at least monthly during treatment with NINLARO. Consider more frequent monitoring during the first three cycles. Manage thrombocytopenia with dose modifications
FAQs – Medicine Questions
What is ixazomib used to treat?
Is ixazomib considered chemotherapy?
How long do you take ixazomib?
Where can I buy Ixazomib Capsules?
You can buy Ixazomib Capsules from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.
The buyer should check the existing law in their home country before importing the product.
What is the procedure to buy Ixazomib Capsules?
Patients can simply fill the order form or can send mail at info@lucknowpharma.com Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Ixazomib Capsule price as well as procurement procedure.
Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.
Is ixazomib FDA approved?
NEWS / UPDATES